Zenshine Pharmaceuticals (Nanjing) Group

Nanjing, China · Founded 2018 · In IPO Registration

Developer and provider of innovative antiviral and oncology therapies designed for unmet clinical needs in viral infections, cancer, and inflammatory diseases. Zenshine Pharmaceuticals (Nanjing) Group is based in Nanjing, China and was founded in 2018. Its last reported valuation was $354 million in Jan 2026. It has raised $127 million.

Last reported valuation
$354.4M
Oct 2026
Priced at
—
Total raised
$126.6M
Last round
—

Who backs Zenshine Pharmaceuticals (Nanjing) Group?

21 investors
InvestorType
China Capital ManagementGrowth equity
CMG SDIC FundVenture capital
Tailong VCOther
Proxima Ventures (China)Venture capital
Changxing FundOther
Hankang CapitalVenture capital
Ennovation VenturesOther
In CapitalOther
Jingjie InvestmentOther
Yang Zi Investment GroupOther
+ 11 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Zenshine Pharmaceuticals (Nanjing) Group investors

21 investors are on record for Zenshine Pharmaceuticals (Nanjing) Group, including China Capital Management, CMG SDIC Fund, Tailong VC and Proxima Ventures (China).

Free account
More of Zenshine Pharmaceuticals (Nanjing) Group with a free account
  • ·The complete investor list: 21 names
  • ·Watch Zenshine Pharmaceuticals (Nanjing) Group: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 21 firms already write checks for companies like Zenshine Pharmaceuticals (Nanjing) Group. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View